Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

Submitted by admin on July 10, 2024 - 11:18am
Source: 
Clinical Trials Arena
News Tags: 
Amylyx
Relyvrio
clinical trials
avexitide
Eiger BioPharmaceuticals
Headline: 
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
snippet: 

Amylyx Pharmaceuticals is looking to rebuild its pipeline after dropping Relyvrio and acquiring a Phase III ready glucagon-like peptide 1 receptor antagonist (GLP1-RA), avexitide, from bankrupt Eiger BioPharmaceuticals in a $35.1m deal.

Do Not Allow Advertisers to Use My Personal information